Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$109,052,184
+$31,300,347 QoQ
Shares Held
90,920
+7.6% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
1.41%
of 13F equity value
Holder Rank
#366
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ethic Inc. holds $332,739,634 across 14 Drug Manufacturers - General names. LLY ranks #1 (32.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
90,920 | $109,052,184 | |
| 2 | MRK |
Merck & Co., Inc.
|
358,041 | $46,008,268 | |
| 3 | JNJ |
Johnson & Johnson
|
109,758 | $27,875,239 | |
| 4 | PFE |
Pfizer Inc
|
882,175 | $21,242,774 | |
| 5 | ABBV |
AbbVie Inc.
|
83,563 | $21,027,793 | |
| 6 | AMGN |
Amgen Inc
|
56,184 | $20,345,350 | |
| 7 | NVS |
Novartis AG
|
108,784 | $17,048,628 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
270,904 | $15,609,488 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $109,052,184 | 90,920 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $77,751,837 | 84,534 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $87,764,825 | 81,666 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $57,917,804 | 75,908 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $59,488,272 | 76,313 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $62,924,431 | 76,188 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $58,784,712 | 76,146 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $61,809,375 | 69,767 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $67,091,374 | 74,103 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $54,275,935 | 69,767 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $36,439,495 | 62,512 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $32,535,038 | 60,572 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $26,034,486 | 55,513 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $18,747,984 | 54,592 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $17,954,695 | 49,078 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $13,921,834 | 43,055 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,057,789 | 37,189 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $4,557,292 | 15,914 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $7,083,109 | 25,643 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,798,015 | 12,110 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,064,302 | 8,994 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,471,628 | 13,230 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,941,997 | 11,502 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,345,797 | 9,092 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $1,286,514 | 7,836 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $915,829 | 6,602 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||